Scientific Publications Database

Article Title: A phase I study of a PD-L1 antibody (Durvalumab) in combination with trastuzumab in HER-2 positive metastatic breast cancer (MBC) progressing on prior anti HER-2 therapies (CCTG IND.229)[NCT02649686]
Authors: Chia, Stephen K. L.; Bedard, Philippe L.; Hilton, John; Amir, Eitan; Gelmon, Karen A.; Goodwin, Rachel Anne; Villa, Diego; Cabanero, Michael; Ritter, Heather; Tu, Dongsheng; Tsao, Ming Sound; Seymour, Lesley
Journal: JOURNAL OF CLINICAL ONCOLOGY Volume 36 Issue 15
Date of Publication:2018
Abstract:
.